|1.||Urinary Tract Infections (Urinary Tract Infection)
|3.||Pharyngitis (Sore Throat)
|5.||Aphthous Stomatitis (Aphthous Ulcer)
|1.||Azevedo, Vasco: 6 articles (11/2014 - 03/2011)|
|2.||Miyoshi, Anderson: 4 articles (11/2014 - 03/2011)|
|3.||Portela, Ricardo W: 4 articles (01/2014 - 03/2011)|
|4.||Lindeboom, Jerome A: 4 articles (01/2011 - 12/2006)|
|5.||Sviland, Lisbet: 3 articles (01/2014 - 04/2008)|
|6.||Moura-Costa, Lilia F: 3 articles (01/2013 - 03/2011)|
|7.||Meyer, Roberto: 3 articles (01/2013 - 03/2011)|
|8.||Bastos, Bruno L: 3 articles (01/2013 - 03/2011)|
|9.||Ohshima, Koichi: 3 articles (12/2010 - 05/2002)|
|10.||Meyer, R: 3 articles (02/2010 - 04/2004)|
|1.||Anti-Bacterial Agents (Antibiotics)IBA
12/01/2008 - "Surgical excision still is the backbone in the management of cervicofacial non-tuberculous mycobacterial lymphadenitis, although a considerable number of children can be cured with antibiotics alone or combined modality treatment. "
10/01/2015 - "The patient eventually needed surgery due to persistence of the adenitis despite treatment with antibiotics. "
11/01/2014 - "Three cases were treated by antibiotics alone (2 cases of lymphadenitis and 1 case of retropharyngeal oedema). "
01/01/2013 - "The patient was treated by antibiotics for a few weeks, with surgical incision and drainage of the purulent lymphadenitis. "
08/01/2011 - "All of them presented with tonsillopharyngitis and cervical lymphadenitis and all were resistant to beta lactam or cephalosporin group antibiotics. "
|2.||Cyclosporine (Ciclosporin)FDA LinkGeneric
12/01/2010 - "A multicentre placebo-controlled clinical trial on the efficacy of oral ciclosporin A in the treatment of canine idiopathic sebaceous adenitis in comparison with conventional topical treatment."
01/01/2005 - "To evaluate the effects of cyclosporine A in the treatment of sebaceous adenitis in dogs. "
01/01/2005 - "Effects of cyclosporine A on clinical and histologic abnormalities in dogs with sebaceous adenitis."
05/01/1991 - "These mechanisms may explain the beneficial response of cyclosporine in the treatment of granulomatous sebaceous adenitis in this dog."
05/01/1991 - "Cyclosporine-responsive granulomatous sebaceous adenitis in a dog."
12/01/1999 - "Vaccination with genetically detoxified phospholipase D (DeltaPLD) has been shown to be effective, at least partially, against Corynebacterium pseudotuberculosis, the causal agent of caseous lymphadenitis in sheep. "
02/26/1999 - "Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D."
12/01/1995 - "Caseous lymphadenitis vaccine development: site-specific inactivation of the Corynebacterium pseudotuberculosis phospholipase D gene."
04/01/1982 - "Twenty-five strains of Corynebacterium pseudotuberculosis isolated from lesions of caseous lymphadenitis in goats were examined for their biochemical characteristics, antimicrobial susceptibility, and phospholipase D activity. "
06/01/1990 - "Corynebacterium pseudotuberculosis produces a sphingomyelin-specific phospholipase D exotoxin that is a major determinant in the pathogenesis of caseous lymphadenitis. "
10/01/1991 - "Immunisation against ovine caseous lymphadenitis: efficacy of monocomponent Corynebacterium pseudotuberculosis toxoid vaccine and combined clostridial-corynebacterial vaccines."
11/01/1997 - "5. Complications with BCG Second IUATLD study (1988) on complications induced by BCG was reviewed, especially following two points: 1-2) Regional suppurative lymphadenitis 3) Generalized lesions: fatal cases 1-2 Several African regions had experienced that the risk of outbreak of suppurative BCG lymphadenitis was low for vaccines with Glaxo and Japanese strains, but much higher for vaccines with Pasteur. "
01/01/2014 - "rCP40 is a promising target in the development of vaccines against caseous lymphadenitis."
05/01/2012 - "The model obtained may provide structural insights into this enzyme and can be useful for the design of new caseous lymphadenitis vaccines based on genetic attenuation from key point mutation."
01/01/2003 - "To estimate the prevalence of caseous lymphadenitis (CLA), determine the current usage of vaccines against CLA and to measure the effectiveness of these vaccines on sheep farms. "
|5.||butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB)IBA
01/01/2014 - "We found no positive IGRA test results among children with NTM not sharing the RD1-region of MTB resulting in a 100% specificity and we suggest that a QFT in a child presenting with cervical lymphadenitis may be helpful in distinguishing NTM from TB lymphadenitis."
06/01/2014 - "Although based on a limited sample size, our study indicates that Xpert MTB/RIF is a useful method for the diagnosis of cervical TB lymphadenitis in HIV-infected patients, regardless of the bacillary load in smear-positive samples or the CD4 T cell count. "
01/01/2001 - "The role of epidemiological and clinical features for the early differential diagnosis between Mycobacterium tuberculosis (MTB) complex and non-tuberculous mycobacterial (NTM) cervical lymphadenitis in children was examined in this study. "
09/01/2014 - "FNAB and Xpert MTB/RIF enable a rapid diagnosis in pediatric mycobacterial lymphadenitis, expediting appropriate treatment and potentially preventing morbidity and mortality."
06/01/2014 - "Xpert MTB/RIF for diagnosis of tuberculous cervical lymphadenitis in HIV-infected patients."
|6.||Erythromycin (Erycette)FDA LinkGeneric
02/01/1993 - "A randomized placebo-controlled prospective trial was conducted to evaluate the efficacy of erythromycin therapy in 69 patients affected with Bacillus Calmette-Guérin lymphadenitis. "
06/01/2002 - "Non-suppurative BCG lymphadenitis is best managed with expectant follow ups only, because medical treatment with erythromycin or antituberculous drugs do not hasten the regression or prevent development of suppuration. "
02/01/1993 - "When patients who developed subsequent regional abscesses were excluded, erythromycin caused significantly earlier resolution of lymphadenitis (5.1 months vs. 5.7 months for placebo; P < 0.01) compared with placebo. "
06/01/1998 - "Comparison of oral erythromycin, local administration of streptomycin and placebo therapy for nonsuppurative Bacillus Calmette-Guérin lymphadenitis."
02/01/1993 - "Evaluation of oral erythromycin and local isoniazid instillation therapy in infants with Bacillus Calmette-Guérin lymphadenitis and abscesses."
11/15/2008 - "Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canindé goats and their potential protection against caseous lymphadenitis."
01/01/2014 - "Both secretory and somatic antigens were expressed in abundance in pulmonary infiltrates, while primarily somatic antigens were detected in the lymphadenitis cases. "
07/01/2007 - "Localized leishmanial lymphadenitis (LLA) is a specific clinico-pathologic presentation of inflammatory changes caused by leishmanial parasites or antigen within an isolated lymph node without any systemic manifestation. "
01/01/2006 - "In three pigs experimentally infected with PCV2, viral antigen was also associated with obliterated blood vessels in areas of granulomatous and necrotizing lymphadenitis. "
04/01/2004 - "PBMC from HIV-negative TB lymphadenitis patients proliferated in response to both antigens (p<0.001) and produced variably higher levels of IFN-gamma compared to healthy controls (p=0.02) (n=19) from the same area. "
01/01/2009 - "The tuberculin test (PPD) was positive in all patients with TB adenitis (100%), while an HIV test was negative in all. "
12/15/2006 - "Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children."
11/15/2001 - "Skin indurations in response to tuberculin testing in patients with nontuberculous mycobacterial lymphadenitis."
05/01/1997 - "A thorough history and physical examination, tuberculin test, and fine-needle aspiration will help arrive at an early diagnosis of tuberculous cervical adenitis and allow early commencement of treatment before final diagnosis can be made by incisional biopsy and culture. "
12/01/1995 - "A 3-year-old boy had lymphadenitis coli since one year despite antituberculosis therapy which was initiated because of the histopathological picture and a positive tuberculin reaction (despite negative mycobacteria-cultures and -PCR). "
|9.||biapenem (L 627)IBA
07/01/1994 - "Those patients who responded well to L-627 treatment included 11 children with pneumonia, 1 with scarlet fever, 1 with cervical lymphadenitis, 2 with cellulitis, 6 with urinary tract infection. "
07/01/1994 - "Clinical and pharmacokinetic studies were performed on a new carbapenem antibiotic, biapenem (L-627), in children with acute infectious diseases and the results were as follows: 1) Clinical efficacies were evaluated on the intravenous-administration at daily doses of 17-37.5 mg/kg for 4-7 consecutive days in 12 children; 8 children with pneumonia, 2 with cervical lymphadenitis, 1 with pyelonephritis and 1 with suspected sepsis. "
|10.||Clarithromycin (Biaxin)FDA LinkGeneric
12/24/1994 - "Clarithromycin for atypical mycobacterial lymphadenitis in non-immunocompromised children."
07/01/1993 - "Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol."
01/15/2011 - "In children with an advanced stage of nontuberculous mycobacterial cervicofacial lymphadenitis, we observed no significant differences in median healing time between the wait-and-see group and the group receiving clarithromycin and rifabutin antibiotic therapy."
11/01/2009 - "One hundred children with microbiologically proven nontuberculous mycobacterial cervicofacial lymphadenitis were randomly assigned to excision of the involved lymph nodes, or antibiotic therapy consisting of clarithromycin and rifabutin. "
04/15/2007 - "One hundred children with microbiologically proven nontuberculous mycobacterial cervicofacial lymphadenitis were randomly assigned to undergo surgical excision of the involved lymph nodes or to receive antibiotic therapy with clarithromycin and rifabutin for at least 12 weeks. "
07/01/2011 - "To seek evidence supporting a role for tonsillectomy or adenotonsillectomy in the management of affected children with periodic fever with aphthous stomatitis, pharnygitis, and adenitis (PFAPA) syndrome. "
06/01/2015 - "Periodic Fever, Aphtous stomatitis, Pharyngitis, and Adenitis (PFAPA) is a childhood febrile syndrome that is often cured by tonsillectomy (TE). "
01/01/2008 - "To examine the efficacy of tonsillectomy in ameliorating symptoms and preventing recurrence of episodes in children with PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis, and adenitis). "
01/01/2014 - "Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA)."
07/01/2011 - "Tonsillectomy in children with periodic fever with aphthous stomatitis, pharyngitis, and adenitis syndrome."
|2.||Drug Therapy (Chemotherapy)
10/01/1984 - "Correct diagnosis of TB v NTM disease is essential, since antituberculous chemotherapy was effective for TB adenitis, while excisional biopsy was the treatment of choice for NTM adenopathy. "
05/01/2010 - "A randomized controlled study comparing surgical therapy alone and chemotherapy for NTM lymphadenitis is required."
02/01/2006 - "Nontuberculous mycobacterial adenitis: effectiveness of chemotherapy following incomplete excision."
03/01/2005 - "[Usefulness of chemotherapy associated with surgery in the management of nontuberculous mycobacterial adenitis]."
03/01/2003 - "Primary therapy for 34 foci of NTM cervical lymphadenitis in 30 children consisted of excisional biopsy (n = 8), incision and drainage procedures (n = 14), fine-needle aspiration biopsy (n = 7), observation only (n = 4), and antimycobacterial chemotherapy only (n = 1). "
|3.||Gynecologic Surgical Procedures (Gynecologic Surgery)
01/01/2010 - "Inflammatory BCG adenitis associated with immune reconstitution following allogeneic haematopoietic stem cell transplant in infancy."
11/01/1975 - "Their cells which appear as large pyroninophilic cells on sections, as large very basophilic cells with blastic nuclei and often cytoplasmic vacuoles on smears, as having many polyribosomes and usually no ergastoplasm with conventional electron microscopy, and as large cells of the lymphocytic series with scanning electron microscopy resemble the cells which we described in adenitis in 1955 (9) and in the graft-versus-host-reaction in 1961 (6), which Gowans (15) showed resulted from lymphocyte transformation, and which Dameshek (10) called immunoblasts. "
08/01/2014 - "Spontaneous resolution of post-transplant localized cytomegalovirus lymphadenitis mimicking tumor recurrence."
05/01/2010 - "We present a case of occupationally acquired R equi pneumonia and mediastinal lymphadenitis in a patient that has had a renal transplant and is in receipt of a stable immunosuppression regimen. "
12/01/2002 - "Reactive lymphadenitis was documented in 70.6% of patients undergoing aortic aneurysm graft replacement, in 33.3% undergoing colectomy, in 50% undergoing gastrectomy, in 33.3% undergoing cholocystectomy (33.3%) whereas it was not found in any patient undergoing splenectomy or other type of laparotomy. "
06/01/1999 - "Curettage is a safe and effective means of treating atypical mycobacterial cervicofacial adenitis in children. "
02/01/2012 - "To compare surgical excision with surgical curettage in the treatment of nontuberculous mycobacterial (NMT) cervicofacial lymphadenitis in children. "
10/01/1999 - "Cervicofacial NTM adenitis can be treated with excision or curettage. "
10/01/1999 - "A total of 32 surgical procedures were performed in 25 children with cervicofacial NTM adenitis (mean, 1.3 procedures per patient; range, 1-3): 19 excisional and 13 curettage procedures. "
10/01/1999 - "To assess optimal surgical treatment with excision or curettage techniques in children with cervicofacial nontuberculous mycobacterial (NTM) adenitis. "